GUA-23 - Effect of 5-α reductase inhibitors on the results of transuretral resection of benign prostate hyperplasia

Publication date: December 2019Source: European Urology Supplements, Volume 18, Issue 12Author(s): Sh.I. Giyasov, J.M. Yuldashev, M.Kh. Tukhtamishev, J.S. Saitkulo
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research

Related Links:

Authors: Dominique I, Ecochard R, Morel-Journel N, Terrier JE, Paparel P, Ruffion A, Champetier D Abstract INTRODUCTION: Preoperative information is a key to adherence to treatment for the patients, but may be misunderstood because of its density and complexity. The aim of this study was to assess comprehension and satisfaction of patients about preoperative information of benign prostatic hyperplasia (BPH) surgery. Factors influencing patient understanding were also studied. PATIENTS AND METHODS: It was a monocentric study on questionnaires including every patients planned for BPH surgery, whatever the surgica...
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
Condition:   Benign Prostatic Hyperplasia Interventions:   Device: Holmium laser enucleation of the prostate;   Procedure: Artery embolization of the prostate Sponsor:   Germans Trias i Pujol Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
ConclusionChronic inflammation can induce BPH in rats via EAP model method. When performing drug experiments on the stroma compartments of BPH, the use of the EAP model is a recommendation of the authors based on this study.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
AbstractPurposeIncreasing evidence shows that many metabolic factors are involved in the progression of benign prostatic hyperplasia (BPH). We aimed to assess the relationship between the status of glucose homeostasis and prostate size in aging Chinese males undergoing transurethral resection of the prostate (TURP) for BPH.MethodsA total of 1006 medical records of BPH patients undergoing TURP were reviewed. Prostate size was measured by transrectal ultrasound. Annual total prostate (TP) and transitional zone (TZ) growth rates were calculated. According to the American Diabetes Association criteria, the patients were catego...
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
CONCLUSIONS: Although recognized and referenced as the BPH gold standard for the treatment of prostates over 80 cc, Canadian urology trainees' annual OSP exposure remains extremely limited. Considering the degree of importance given (category A) to the direct observation (of a minimum of five) of this intervention during residency training in the new Royal College's practice guidelines, it may be unrealistic to reach these national standards considering the annual case OSP volumes in Canadian academic urology faculties. PMID: 31977302 [PubMed - as supplied by publisher]
Source: Canadian Urological Association Journal - Category: Urology & Nephrology Authors: Tags: Can Urol Assoc J Source Type: research
To evaluate the efficacy and safety of 1470-nm Diode Laser Enucleation of the Prostate (DiLEP) in patients with benign prostatic hyperplasia (BPH) continuously receiving oral anticoagulants or antiplatelet drugs.
Source: Urology - Category: Urology & Nephrology Authors: Tags: Prostatic Diseases and Male Voiding Dysfunction Source Type: research
ConclusionsThe therapeutic effects of SVCP on treating UTIs might result from the up-regulation of innate immunity in the kidney. SVCP can be used as an alternative therapeutic agent for UTIs.Graphical abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
Conclusions: In conclusion, UBASH3B may be a novel potential prognostic biomarker and is associated with tumor-infiltrating immune cells in tumor microenvironment, suggesting UBASH3B as a potential target for future treatment of PCa.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
CONCLUSION: Our results did not show adequate evidence for any significant association of MLH1 and MSH3 polymorphisms and prostate cancer. PMID: 31953835 [PubMed - as supplied by publisher]
Source: Urology Journal - Category: Urology & Nephrology Authors: Tags: Urol J Source Type: research
This study aims to compare the efficacy and safety of holmium laser technologies (HoL-Ts) and photoselective greenlight vaporization (PVP) for the treatment of benign prostatic hyperplasia (BPH), and to perform a meta-analysis according to the Preferred Reporting Items of Systematic Reviews and Meta-Analyses guidelines on PubMed, EMBASE, ClinicalTrial.gov, and the Cochrane Central Register of Controlled Trials up to August 2019. Functional outcomes, perioperative parameters, and complications were included and analyzed. Review Manager 5.3 (Cochrane Collaboration, Oxford, UK) was used to perform all analyses. A total of six...
Source: Lasers in Medical Science - Category: Laser Surgery Source Type: research
More News: Benign Prostatic Hyperplasia | Urology & Nephrology